 | Up a level |
2017
Jawhar, M., Naumann, N., Knut, M., Schneider, B., Ghazzawi, M., Kreuzer, K-A., Hallek, M., Fabarius, A., Score, J., Chase, A., Tapper, W., Reiter, A. and Cross, N. (2017). ZMYM2-FLT3 IS A RARE, RECURRENT, CYTOGENTICALLY CRYPTIC FUSION IN MYELOID/LYMPHOID NEOPLASMS WITH EOSINOPHILIA THAT IS RESPONSIVE TO FLT3 INHIBITION. Haematologica, 102. S. 553 - 554. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Jawhar, M., Naumann, N., Knut, M., Score, J., Ghazzawi, M., Schneider, B., Kreuzer, K-A, Hallek, M., Drexler, H. G., Chacko, J., Wallis, L., Fabarius, A., Metzgeroth, G., Hofmann, W-K, Chase, A., Tapper, W., Reiter, A. and Cross, N. C. P. (2017). Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia. Leukemia, 31 (10). S. 2271 - 2275. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
Jawhar, M., Naumann, N., Knut, M., Score, J., Ghazzawi, M., Schneider, B., Kreuzer, K. -A., Hallek, M., Chacko, J., Wallis, L., Schwaab, J., Metzgeroth, G., Hofmann, W. -K., Fabarius, A., Chase, A., Tapper, W., Cross, N. C. P. and Reiter, A. (2017). Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasm with eosinophilia. Oncol. Res. Treat., 40. S. 150 - 151. BASEL: KARGER. ISSN 2296-5262
2016
Theurich, S., Iltgen, J., Wennhold, K., Marquez, M. Garcia, Rothschild, S., Schneider, B., Holtick, U., Thelen, M., Scheid, C., Becker, Hj, Schloesser, H., Reuter, S., Vornhagen, A. Shimabukuro and von Bergwelt-Baildon, M. (2016). THE JAK1/2 INHIBITOR RUXOLITINIB MODULATES ANTIGEN PRESENTING FUNCTIONS OF ACTIVATED PRIMARY B CELLS ON A METABOLIC LEVEL. Haematologica, 101. S. 462 - 463. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078